Literature DB >> 15777143

Vitamin D and adult bone health in Australia and New Zealand: a position statement.

.   

Abstract

A significant number of Australians are deficient in vitamin D--it is a fallacy that Australians receive adequate vitamin D from casual exposure to sunlight. People at high risk of vitamin D deficiency include elderly people (particularly those in residential care), people with skin conditions where avoidance of sunlight is advised, those with dark skin (particularly if veiled), and those with malabsorption. Exposure of hands, face and arms to one-third of a minimal erythemal dose (MED) of sunlight (the amount that produces a faint redness of skin) most days is recommended for adequate endogenous vitamin D synthesis. However, deliberate sun exposure between 10:00 and 14:00 in summer (11:00-15:00 daylight saving time) is not advised. If this sun exposure is not possible, then a vitamin D supplement of at least 400 IU (10 microg) per day is recommended. In vitamin D deficiency, supplementation with 3000-5000 IU ergocalciferol per day (Ostelin [Boots]; 3-5 capsules per day) for 6-12 weeks is recommended. Larger-dose preparations of ergocalciferol or cholecalciferol are available in New Zealand, Asia and the United States and would be useful in Australia to treat moderate to severe vitamin D deficiency states in the elderly and those with poor absorption; one or two annual intramuscular doses of 300 000 IU of cholecalciferol have been shown to reverse vitamin D deficiency states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777143     DOI: 10.5694/j.1326-5377.2005.tb06701.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  50 in total

1.  Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill?

Authors:  Bala Venkatesh; Ben Davidson; Katherine Robinson; Ranald Pascoe; Charles Appleton; Mark Jones
Journal:  Intensive Care Med       Date:  2011-11-24       Impact factor: 17.440

Review 2.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

Review 3.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie; David E C Cole; Stephanie A Atkinson; Robert G Josse; Sidney Feldman; Gregory A Kline; Cheryl Rosen
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

4.  Should I prescribe sunlight instead of vitamin D?

Authors:  Diane Kelsall
Journal:  CMAJ       Date:  2010-11-23       Impact factor: 8.262

5.  Emerging role of vitamin D in colorectal cancer.

Authors:  Wonmo Kang; Sujin Lee; Eunyi Jeon; Ye-Rang Yun; Kook-Hyun Kim; Jun-Hyeog Jang
Journal:  World J Gastrointest Oncol       Date:  2011-08-15

6.  Unrecognised severe vitamin D deficiency.

Authors:  John L Sievenpiper; Elizabeth A McIntyre; Mark Verrill; Richard Quinton; Simon H S Pearce
Journal:  BMJ       Date:  2008-06-14

7.  Rickets: a preventable cause of delayed walking in toddlers.

Authors:  R Kishore Kumar
Journal:  Indian J Pediatr       Date:  2010-04       Impact factor: 1.967

Review 8.  A dermatologist's perspective on vitamin D.

Authors:  Veena Vanchinathan; Henry W Lim
Journal:  Mayo Clin Proc       Date:  2012-03-14       Impact factor: 7.616

9.  Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Authors:  Nathan A Hewitt; Alicia A O'Connor; Denise V O'Shaughnessy; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

10.  Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients.

Authors:  Priya Nair; Paul Lee; Claire Reynolds; Nguyen Dinh Nguyen; John Myburgh; John A Eisman; Jacqueline R Center
Journal:  Intensive Care Med       Date:  2012-10-13       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.